Form 4: Elanco Director Receives Equity Awards
Statement of Changes in Beneficial Ownership
Kirk P. McDonald, a Director at Elanco Animal Health Inc., received deferred stock units and restricted stock units as part of annual equity awards.
Summary
- Kirk P. McDonald, a Director at Elanco Animal Health Inc. (ELAN), was granted equity awards on May 21, 2026.
- The awards include 4,678 deferred stock units and 12,196 restricted stock units.
- These grants are described as pro-rated annual equity awards for non-employee directors and annual equity awards for non-employee directors, respectively.
- Following these transactions, McDonald beneficially owns 93,392 shares from the deferred stock units and 105,588 shares from the restricted stock units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity awards to a director and does not contain significant financial performance data or strategic shifts.
Positives
- Director compensation through equity awards indicates alignment of management interests with shareholders.
- The granting of both deferred stock units and restricted stock units suggests a multi-faceted approach to long-term incentive compensation.
Future Outlook
This filing does not contain forward-looking statements or guidance; it reports on equity awards granted to a director.
Industry Context
StockSavvy.ai notes that the issuance of equity awards to directors is a common practice in the animal health industry to incentivize long-term performance and align executive interests with shareholders. This type of disclosure is standard for publicly traded companies under SEC regulations.
Stakeholder Impact
- Shareholders: The equity awards are intended to align director interests with long-term shareholder value creation.
- Employees: This filing does not directly impact employees, but reflects standard compensation practices for non-employee directors.
Key Dates
| Date | Description |
|---|---|
| 05/21/2026 | Earliest transaction date and date of equity award grants. |
| 05/26/2026 | Signature date on the Form 4 filing. |
Keywords
Elanco Animal Health, ELAN, Form 4, SEC Filing, Director Equity Award, Deferred Stock Units, Restricted Stock Units, Beneficial Ownership, Securities Exchange Act
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.